PubMed:10229231
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-24 | protein | denotes | Fas ligand |
| T2 | 54-77 | DNA | denotes | apoptosis-linked gene 4 |
| T3 | 222-235 | cell_type | denotes | T lymphocytes |
| T4 | 255-258 | protein | denotes | Fas |
| T5 | 258-269 | protein | denotes | /Fas ligand |
| T6 | 271-275 | protein | denotes | FasL |
| T7 | 371-377 | protein | denotes | ALG-4F |
| T8 | 381-401 | protein | denotes | truncated transcript |
| T9 | 440-444 | protein | denotes | FasL |
| T10 | 492-509 | protein | denotes | full-length ALG-4 |
| T11 | 535-539 | protein | denotes | FasL |
| T12 | 598-603 | protein | denotes | ALG-4 |
| T13 | 636-640 | protein | denotes | FasL |
| T14 | 657-661 | protein | denotes | FasL |
| T15 | 843-847 | protein | denotes | FasL |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-78 | Sentence | denotes | Regulation of Fas ligand expression and cell death by apoptosis-linked gene 4. |
| S2 | 79-165 | Sentence | denotes | Programmed cell death is a process required for the normal development of an organism. |
| S3 | 166-289 | Sentence | denotes | One of the best understood apoptotic pathways occurs in T lymphocytes and is mediated by Fas/Fas ligand (FasL) interaction. |
| S4 | 290-473 | Sentence | denotes | During studies of apoptosis induced by T cell-receptor engagement, we identified ALG-4F, a truncated transcript that prevents T cell-receptor-induced FasL upregulation and cell death. |
| S5 | 474-569 | Sentence | denotes | Overexpression of full-length ALG-4 induced transcription of FasL and, consequently, apoptosis. |
| S6 | 570-652 | Sentence | denotes | These results indicate that ALG-4 is necessary and sufficient for FasL expression. |
| S7 | 653-800 | Sentence | denotes | Fas/FasL interaction initiates cell death in many other systems, and its dysregulation is a mechanism by which several pathologic conditions arise. |
| S8 | 801-971 | Sentence | denotes | Understanding the molecular mechanisms of FasL regulation could be very useful in elucidating how these diseases develop and in identifying potential therapeutic targets. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 14-35 | NP | denotes | Fas ligand expression |
| C1 | 0-35 | NP | denotes | Regulation of Fas ligand expression |
| C3 | 40-50 | NP | denotes | cell death |
| C4 | 255-288 | NP | denotes | Fas/Fas ligand (FasL) interaction |
| C5 | 371-377 | NP | denotes | ALG-4F |
| C7 | 379-401 | NP | denotes | a truncated transcript |
| C8 | 402-406 | NP | denotes | that |
| C9 | 462-472 | NP | denotes | cell death |
| C6 | 379-472 | NP | denotes | a truncated transcript that prevents T cell-receptor-induced FasL upregulation and cell death |
| C10 | 598-603 | NP | denotes | ALG-4 |
| C11 | 636-651 | NP | denotes | FasL expression |
| C12 | 653-673 | NP | denotes | Fas/FasL interaction |
| C13 | 722-725 | NP | denotes | its |
| C14 | 743-754 | NP | denotes | a mechanism |
| C15 | 758-763 | NP | denotes | which |
| C16 | 843-858 | NP | denotes | FasL regulation |
| R1 | C8 | C7 | coref-relat | that,a truncated transcript |
| R2 | C9 | C3 | coref-ident | cell death,cell death |
| R3 | C6 | C5 | coref-appos | a truncated transcript that prevents T cell-receptor-induced FasL upregulation and cell death,ALG-4F |
| R4 | C10 | C5 | coref-ident | ALG-4,ALG-4F |
| R5 | C11 | C2 | coref-ident | FasL expression,Fas ligand expression |
| R6 | C12 | C4 | coref-ident | Fas/FasL interaction,Fas/Fas ligand (FasL) interaction |
| R7 | C13 | C12 | coref-pron | its,Fas/FasL interaction |
| R8 | C15 | C14 | coref-relat | which,a mechanism |
| R9 | C16 | C1 | coref-ident | FasL regulation,Regulation of Fas ligand expression |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-24 | protein_molecule | denotes | Fas ligand |
| T2 | 40-50 | other_name | denotes | cell death |
| T3 | 54-77 | DNA_domain_or_region | denotes | apoptosis-linked gene 4 |
| T4 | 90-100 | other_name | denotes | cell death |
| T5 | 131-149 | other_name | denotes | normal development |
| T6 | 193-211 | other_name | denotes | apoptotic pathways |
| T7 | 222-235 | cell_type | denotes | T lymphocytes |
| T8 | 255-258 | protein_molecule | denotes | Fas |
| T9 | 258-269 | protein_molecule | denotes | /Fas ligand |
| T10 | 271-275 | protein_molecule | denotes | FasL |
| T11 | 308-317 | other_name | denotes | apoptosis |
| T12 | 329-355 | other_name | denotes | T cell-receptor engagement |
| T13 | 371-377 | protein_molecule | denotes | ALG-4F |
| T14 | 381-401 | protein_molecule | denotes | truncated transcript |
| T15 | 416-439 | other_name | denotes | T cell-receptor-induced |
| T16 | 440-444 | protein_molecule | denotes | FasL |
| T17 | 462-472 | other_name | denotes | cell death |
| T18 | 492-509 | protein_molecule | denotes | full-length ALG-4 |
| T19 | 518-531 | other_name | denotes | transcription |
| T20 | 535-539 | protein_molecule | denotes | FasL |
| T21 | 559-568 | other_name | denotes | apoptosis |
| T22 | 598-603 | protein_molecule | denotes | ALG-4 |
| T23 | 636-640 | protein_molecule | denotes | FasL |
| T24 | 653-657 | other_name | denotes | Fas/ |
| T25 | 657-661 | protein_molecule | denotes | FasL |
| T26 | 684-694 | other_name | denotes | cell death |
| T27 | 819-839 | other_name | denotes | molecular mechanisms |
| T28 | 843-847 | protein_molecule | denotes | FasL |
| T29 | 941-970 | other_name | denotes | potential therapeutic targets |